home.social

#medicalbreakthrough — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #medicalbreakthrough, aggregated by home.social.

fetched live
  1. SUPERCHARGED “KILLER” CELLS IMPROVE SOLID TUMOR IMMUNOTHERAPY. New methodology “supercharges” natural killer cells and improves their ability to infiltrate solid tumors. #CancerResearch #Immunotherapy #NaturalKillerCells #CancerTreatment #MedicalBreakthrough
    instagram.com/p/DdVeXfUBO_Y/

  2. SUPERCHARGED “KILLER” CELLS IMPROVE SOLID TUMOR IMMUNOTHERAPY. New methodology “supercharges” natural killer cells and improves their ability to infiltrate solid tumors. #CancerResearch #Immunotherapy #NaturalKillerCells #CancerTreatment #MedicalBreakthrough
    instagram.com/p/DdVeXfUBO_Y/

  3. DATE: September 13, 2026 at 09:56AM
    SOURCE: SCIENCE DAILY PSYCHOLOGY FEED

    TITLE: Scientists find a new layer of Alzheimer’s hidden in the genome

    URL: sciencedaily.com/releases/2026

    Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersResearch #Genomics #3DGenome #BrainHealth #Gene Regulation #Neuroscience #AlzheimersAwareness #DNAArchitecture #NeurodegenerativeDisease #MedicalBreakthrough

  4. DATE: September 13, 2026 at 09:56AM
    SOURCE: SCIENCE DAILY PSYCHOLOGY FEED

    TITLE: Scientists find a new layer of Alzheimer’s hidden in the genome

    URL: sciencedaily.com/releases/2026

    Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersResearch #Genomics #3DGenome #BrainHealth #Gene Regulation #Neuroscience #AlzheimersAwareness #DNAArchitecture #NeurodegenerativeDisease #MedicalBreakthrough

  5. DATE: September 13, 2026 at 09:56AM
    SOURCE: SCIENCE DAILY PSYCHOLOGY FEED

    TITLE: Scientists find a new layer of Alzheimer’s hidden in the genome

    URL: sciencedaily.com/releases/2026

    Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersResearch #Genomics #3DGenome #BrainHealth #Gene Regulation #Neuroscience #AlzheimersAwareness #DNAArchitecture #NeurodegenerativeDisease #MedicalBreakthrough

  6. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  7. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  8. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  9. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  10. In August, #RFKJr’s #HHS followed up by announcing it would no longer fund #mRNA #research through the Biomedical Advanced Research & Development Authority. The latter move involved the cancellation of 22‼️ separate contracts.

    After the #FDA initially declined to review #Moderna’s mRNA-based #flu #vaccine because of the design of the company’s clinical trial, the agency recently approved it.

    #Melanoma #cancer #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  11. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  12. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  13. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  14. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  15. Experts say major safety concerns are unfounded, but #government #funding for #mRNA, particularly for its use against respiratory viruses, has been slashed during #Trump’s 2nd admin, driving concerns that mRNA innovation could stall.

    #RFKJr’s #HHS last year CANCELLED a $590 million deal with #Moderna to develop an mRNA-based #vaccine against emerging pandemic influenza.

    #Melanoma #cancer #PublicHealth #health #science #medicine #MedicalBreakthrough

  16. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  17. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  18. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  19. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  20. Messenger RNA, or #mRNA, is a single-stranded molecule that delivers genetic information to direct the formation of proteins. Before it was used in #vaccines against #Covid19, mRNA was stirring excitement among #cancer researchers.

    However, the technology has faced backlash in the wake of the pandemic, with some [ #ConspiracyTheories ] questioning the safety of mRNA.

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  21. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  22. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  23. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  24. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  25. Karen Knudsen, CEO of the Parker Institute for #Cancer ⁠Immunotherapy, said the Moderna results could signal a new era for treating solid-tumor #cancers.

    “The positive hit here leads us into truly this next phase in #immunotherapy,” Knudsen said. “This is an auspicious start — this is where things begin.”

    #Melanoma #vaccine #PublicHealth #health #science #medicine #MedicalBreakthrough

  26. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  27. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  28. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  29. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  30. In January, the companies announced results of a mid-stage trial of the treatment showing ⁠that it reduced the risk of recurrence or death by 49% after 5 years.

    #Melanoma is the deadliest form of skin #cancer. In 2023, there were >1.5 million people in the US living with melanoma, acc/to the National Cancer Institute.

    The companies said they will present their results at an upcoming medical meeting & share them ⁠with regulators.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  31. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  32. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  33. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  34. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  35. The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

    Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  36. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  37. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  38. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  39. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  40. “For many years, the idea of creating an #mRNA treatment designed specifically for an individual patient’s #cancer was aspirational,” Bancel said in a statement. “We are now helping turn that vision into a reality.”

    The cancer ‌treatment ⁠combines Keytruda with a made-to-order mRNA #vaccine that is based on an analysis of mutations found in the patients’ own tumors.

    #melanoma #PublicHealth #health #science #medicine #MedicalBreakthrough

  41. The results are “as big a day for humanity as Nov. 16, 2020,” when #Moderna released late-stage clinical trial results showing its #Covid19 #vaccine worked, the company’s chief executive, Stephane Bancel, told CNN Wednesday. “This is a new chapter in #cancer care.”

    Moderna said the company & partner #Merck aim to file for approval from regulators within months, though they declined to provide a more specific timeline.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  42. The results are “as big a day for humanity as Nov. 16, 2020,” when #Moderna released late-stage clinical trial results showing its #Covid19 #vaccine worked, the company’s chief executive, Stephane Bancel, told CNN Wednesday. “This is a new chapter in #cancer care.”

    Moderna said the company & partner #Merck aim to file for approval from regulators within months, though they declined to provide a more specific timeline.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  43. The results are “as big a day for humanity as Nov. 16, 2020,” when #Moderna released late-stage clinical trial results showing its #Covid19 #vaccine worked, the company’s chief executive, Stephane Bancel, told CNN Wednesday. “This is a new chapter in #cancer care.”

    Moderna said the company & partner #Merck aim to file for approval from regulators within months, though they declined to provide a more specific timeline.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  44. The results are “as big a day for humanity as Nov. 16, 2020,” when #Moderna released late-stage clinical trial results showing its #Covid19 #vaccine worked, the company’s chief executive, Stephane Bancel, told CNN Wednesday. “This is a new chapter in #cancer care.”

    Moderna said the company & partner #Merck aim to file for approval from regulators within months, though they declined to provide a more specific timeline.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  45. The results are “as big a day for humanity as Nov. 16, 2020,” when #Moderna released late-stage clinical trial results showing its #Covid19 #vaccine worked, the company’s chief executive, Stephane Bancel, told CNN Wednesday. “This is a new chapter in #cancer care.”

    Moderna said the company & partner #Merck aim to file for approval from regulators within months, though they declined to provide a more specific timeline.

    #PublicHealth #health #science #medicine #MedicalBreakthrough

  46. England May Soon Achieve What Most Nations Thought Was Impossible

    Public health victories rarely make front page headlines, but England appears to be standing on the threshold of…
    #NewsBeep #News #Healthcare #AU #Australia #England #Health #medicalbreakthrough
    newsbeep.com/au/852366/

  47. England May Soon Achieve What Most Nations Thought Was Impossible

    Public health victories rarely make front page headlines, but England appears to be standing on the threshold of…
    #NewsBeep #News #Healthcare #AU #Australia #England #Health #medicalbreakthrough
    newsbeep.com/au/852366/